|
HS Code |
715831 |
| Product Name | Suxamethonium Chloride Veterinary Grade API |
| Chemical Formula | C14H30Cl2N2O4 |
| Molecular Weight | 361.31 g/mol |
| Appearance | White crystalline powder |
| Solubility | Freely soluble in water |
| Intended Use | Muscle relaxant in veterinary medicine |
| Dosage Forms | Tablets, Injections, Capsules, Powders, Granules, Premix, Solutions |
| Storage Conditions | Store below 25°C, protected from light and moisture |
| Cas Number | 306-43-4 |
As an accredited Suxamethonium Chloride Veterinary Grade API for Tablets / Injections / Capsules / Powders / Granules / Premix / Solutions factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | Packed in a 25 kg fiber drum with inner double polyethylene liners, labeled "Suxamethonium Chloride Veterinary Grade API." |
| Shipping | Suxamethonium Chloride Veterinary Grade API is securely packed in tamper-evident, moisture-resistant containers and shipped according to international regulations for hazardous materials. All packages include detailed labeling and shipping documentation to ensure safe and compliant transport for use in tablets, injections, capsules, powders, granules, premix, and solutions. |
| Storage | Suxamethonium Chloride Veterinary Grade API should be stored in a tightly sealed container, protected from light and moisture, at a temperature below 25°C. Store in a cool, dry, well-ventilated area, away from incompatible substances. Ensure all packaging is clearly labeled and kept out of reach of unauthorized personnel. Follow standard pharmaceutical storage guidelines to maintain stability and prevent contamination. |
|
Purity 99.8%: Suxamethonium Chloride Veterinary Grade API for Tablets / Injections / Capsules / Powders / Granules / Premix / Solutions with a purity of 99.8% is used in neuromuscular blockade protocols in veterinary surgeries, where it ensures rapid and predictable onset of muscle relaxation. Particle Size D90 < 50μm: Suxamethonium Chloride Veterinary Grade API for Tablets / Injections / Capsules / Powders / Granules / Premix / Solutions with particle size D90 less than 50 microns is used in the formulation of oral veterinary tablets, where it provides enhanced dissolution and uniform absorption profiles. Sterility Certified: Suxamethonium Chloride Veterinary Grade API for Tablets / Injections / Capsules / Powders / Granules / Premix / Solutions with sterility certification is used in injectable veterinary solutions, where it minimizes the risk of contamination and ensures product safety during administration. Stability at 25°C: Suxamethonium Chloride Veterinary Grade API for Tablets / Injections / Capsules / Powders / Granules / Premix / Solutions with stability at 25°C is used in manufacturing veterinary premixes, where it guarantees prolonged shelf life and maintains pharmacological efficacy during storage. Moisture Content < 2%: Suxamethonium Chloride Veterinary Grade API for Tablets / Injections / Capsules / Powders / Granules / Premix / Solutions with moisture content less than 2% is used in veterinary oral granules, where it prevents caking and ensures optimal flow properties in automated processing. pH 4.5-6.5: Suxamethonium Chloride Veterinary Grade API for Tablets / Injections / Capsules / Powders / Granules / Premix / Solutions with a pH range of 4.5 to 6.5 is used in compounded veterinary solutions, where it enhances chemical stability and reduces the risk of active ingredient degradation. Endotoxin Level < 0.25 EU/mg: Suxamethonium Chloride Veterinary Grade API for Tablets / Injections / Capsules / Powders / Granules / Premix / Solutions with endotoxin level below 0.25 EU/mg is used in parenteral veterinary administrations, where it ensures low pyrogenicity and minimizes adverse reactions in animals. Melting Point 175-177°C: Suxamethonium Chloride Veterinary Grade API for Tablets / Injections / Capsules / Powders / Granules / Premix / Solutions with a melting point of 175-177°C is used in high-temperature tablet manufacturing processes, where it maintains chemical integrity throughout production. |
Competitive Suxamethonium Chloride Veterinary Grade API for Tablets / Injections / Capsules / Powders / Granules / Premix / Solutions prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please contact us at +8615365186327 or mail to admin@ascent-chem.com.
We will respond to you as soon as possible.
Tel: +8615365186327
Email: admin@ascent-chem.com
Flexible payment, competitive price, premium service - Inquire now!
Years on the production floor—we've seen the value animals bring not only to the food chain but also to countless veterinary procedures that call for trust in pharmaceuticals. At the heart of safe and humane anesthetic procedures stands Suxamethonium Chloride, a neuromuscular blocker that delivers controlled muscle relaxation for short-term procedures and intubations. While some may only know this product by batch numbers or spec sheets, here we know the process, the technical challenges, the scrutiny that must surround every manufactured gram. Through daily production, batch release, internal audits, and hundreds of customer conversations, we’ve built an expertise that translates to authentic quality every step.
Every lot of Suxamethonium Chloride Veterinary Grade API starts with a raw material check, precise temperature control, and consistent agitation during synthesis. Each production run delivers an API intended not for faceless markets, but for veterinarians who need fast-acting, reliable muscle relaxation in their patients. Potency isn’t a theoretical concern—animals rely on fast onset and a predictable return of movement after the procedure. Veterinary teams see the difference immediately when a product brings the right onset profile: a few seconds for induction, a limited window for intervention, and a reliable offset to support recovery. Our high-purity model meets pharmaceutical requirements for tablets, injectables, capsules, powders, granules, premix formulations, and in-solution forms.
On the line, we aim for Suxamethonium Chloride with robust crystalline properties, minimal particulate load, and a stability profile that withstands ambient conditions common in animal clinics and livestock management facilities. The most widely adopted model follows monograph guidance. Our veterinary grade Suxamethonium Chloride (often as the dichloride dihydrate) tests out with purity exceeding 99%—rejecting batches outside a narrow specification range. Moisture content, particle size, pH, and sodium content face repeated checks to root out regulatory issues before release.
Where some producers cut corners to meet minimal specifications, our plant keeps batch records open to audits, not just for regulatory visits but also for our own internal accountability. Shelf life doesn't exist on paper—it gets monitored in real samples in our stability chambers and tracked against customer inventory lifecycles. Experience has shown us chronic moisture pickup can alter flow properties in powders and cause caking in granules, so desiccation protocols became part of our packing routine. Most clients working with tablet presses or powder fillers comment on ease of handling—our in-process controls check flowability before and after granulation. This detail matters for feed premix plants where caking at the auger or hopper throws off metering for animal rations.
Veterinarians come to us with challenging requirements. Livestock transport, surgical procedures in companion animals, and laboratory settings all demand different modes of administration. That’s influenced our production philosophy: every batch should offer reproducibility whether it's dissolved for injection, pressed into tablets, or mixed into a soluble premix. We’ve worked with formulation teams adjusting carrier systems—some use starch blends for robust granulation, others require highly soluble API for water-based dosing. When customers need a batch specifically low in extraneous ions for solution formulations, we adapt ionic screening at the crystallization stage instead of waiting to adjust post-processing. This hands-on control ensures veterinarians avoid unexpected excipient interactions at the point of care.
Experienced compounders know Suxamethonium Chloride’s ultra-rapid onset (often measurable in seconds) and its brief duration serve well in acute interventions such as intubation or rapid surgical prep. For injectable preparations, the product dissolves clear with minimal particulate content, tested by filtration and inspection—a critical point that avoids clogging fine-gauge animal-use needles. Veterinary practitioners seek quick action for small ruminants and rapid metabolism in horses or dogs. Reversal or recovery hinges on short activity span, so exact dosing and formulation stability become key. Our batches meet strict impurity profiles to support this precision, reducing the risk of unexpected pharmacological effects.
Human and laboratory grades differ fundamentally from what field veterinarians and feed mills require. Injectable human-use material passes through even tighter controls for endotoxins and bioburden, but the veterinary grade’s distinct challenge lies in handling larger volumes, diverse dosing approaches, and multiple animal species. Some global production routes for muscle relaxants use older crystallization processes, lacking the physical consistency demanded by modern feed and drug manufacturers. We developed our own process controls to hit smaller particle sizes for incorporation into granular premixes and physical blends. In comparison, pharmaceutical companies buying for tablet pressing select between particle sizes as a direct cost-to-performance tradeoff. We provide consistency so they can lock in their formulation targets batch after batch.
Other neuromuscular blockers like pancuronium bromide or vecuronium serve different scenarios—often longer-term relaxation needed in critical care. Suxamethonium Chloride’s rapid hydrolysis by plasma cholinesterase marks it as distinct for short-acting protocols. Formulators often find that only Suxamethonium Chloride delivers the right blend of fast onset and short span for veterinary field conditions. Substituting other agents means taking on longer monitoring or different side effect profiles—a frequent discussion point with our veterinary clients comparing anesthesia protocols.
Factories running successful Suxamethonium Chloride lines don’t rely on textbook protocols alone. Our teams collect process data every shift, noting trends in yield loss, impurity formation, and drying times, then act on these findings to cut waste and fine-tune output. Lot release only follows full ATP and sterility panel completion. In powder form, Suxamethonium Chloride needs both physical integrity and chemical purity, so we run repeat tests for residual solvents and cross-check with independent labs for batch validation. For tablets and capsules, we build pilot studies with real excipient blends before moving to scaled production—smoothing the way for customer manufacturing, especially at contract sites with limited process analytics.
Our packing staff knows moisture sensitivity poses problems for granules and powders meant for automated feed production lines. Nitrogen flushing for larger drums, double-sealing, desiccant canisters—all these details came from real-world complaints. We have watched the evolution of packaging materials after outbreaks of failure from cheaper, permeable plastics. Because our relationship with buyers often stretches over years, not quarters, success rests on feedback loops—not just one-way commerce. Whether we ship to regional pharmaceutical plants or direct to clinical compounding pharmacies, each delivery reflects responsibility carried from reactor to shipment.
Veterinary medicine operates under strict national and international regulations. Product integrity links directly to animal health, food safety, and market access for clients with livestock operations. As a manufacturer, we've experienced unannounced routine compliance audits and know the weight of documentation during recalls or adverse event investigations. Our production logs remain accessible for traceability; each raw material source, each testing step, sits documented, not buried in bureaucracy but as living records to answer regulatory requests. Laboratories with ISO certification sign off our batch testing—chromatography, titration, elemental analysis, and microbiological checks appear in every release package.
We also engage with end buyers—veterinarians, farm managers, pharmaceutical R&D teams—learning about field outcomes, batch stability issues, and formulation challenges. An example: a North American feed manufacturer once reported inconsistent API dispersal in water-soluble premix. Our technical staff traced the issue to excessive fines in an API lot. Two weeks later, our mill settings shifted, and the incident never repeated. Such feedback cycles refine our quality process, pushing tighter sieving and drying protocols.
Every animal species has unique pharmacological needs. Producers of veterinary medicines must balance the active’s chemical stability with challenges of excipient compatibility—especially for water-soluble or in-feed applications. Suxamethonium Chloride Veterinary Grade API supports those demands by offering physical and chemical profiles vets and formulation scientists trust. In practical terms, this means keeping a close eye on flow properties, API-excipient interactions, and even packaging interactions with hygroscopic carriers.
Some innovative feed products demand granular or microencapsulated Suxamethonium Chloride. Manufacturing these forms pushes us to modify our crystallization protocols and test process aids for agglomeration control. Our experience shows that clumping, inappropriate flow, or poor solubility can halt automated mixing systems in large feed mills. To avoid these breakdowns, we work upstream—addressing problems in the reactor, not just at the blending line.
On our factory floor, scaling up a batch from lab reactor to industrial tank doesn’t follow a simple multiplication. Thermal gradients, mixing speed, reactor coatings—every detail can shift final product quality. Our engineering teams spend hours mapping these process changes, ensuring large-scale lots match the profile vets and pharmacists have grown to expect from smaller samples. Crafting the right particle size for granules, achieving consistent dissolution in solutions, and preserving chemical potency all call for continuous adjustment.
Supply interruptions or recalls damage more than reputation—they risk animal lives. Our management invests in dual sourcing of critical precursors, preventive maintenance, quarterly retraining of staff, and cross-training for operators to hedge against sudden staffing shortfalls. We learned through past disruptions that resilience isn’t just a target; it comes from belt-and-suspenders planning and ongoing investment in people and plant.
Our technical staff regularly visit client sites, both large animal veterinary hospitals and rural feed mills. Conversations often focus less on abstract “compliance,” more on shelf life in humid climates, real solubility in hard or soft water, or the impact of small impurity levels in sensitive species. We’ve provided custom packing for hot, humid regions after learning how quickly open drums can absorb moisture on-site. More than once we’ve seen how a small flaw at packaging leads to operational problems, so we continually integrate field data to strengthen future output.
Many animal health companies buy API for secondary processing—injections, drench solutions, or powder blends. They bring practical concerns: “How well does the product dissolve in typical veterinary solvents?” or “Will your granules process smoothly with our standard excipient blends?” Our capacity to provide clear technical answers comes from running simulation blends onsite, not hypotheticals or borrowed claims. Where needed, we’ve offered side batches with alternate sieving or compaction tailored to specific client lines, so operators experience real-world results before making large-scale transitions.
Manufacturing muscle relaxants for animals calls for careful stewardship of both the science and the practice. Analytical chemists keep a close eye on impurities, which can arise not just from starting materials, but from obscure reactor fouling or staff handling errors. Not every error comes from the textbook; sometimes, unexpected shifts happen faster than a sampling routine can detect. We’ve implemented in-line monitoring and rapid-response teams for off-spec deviations, minimizing risk through quick containment and full root-cause analysis. Every plant outage, every customer complaint feeds into our formal corrective tracking, so patterns reveal themselves and drive systematic improvement.
One ongoing challenge remains transportation—especially for temperature- and moisture-sensitive APIs. Our logistics partners undergo training to handle veterinary grade APIs, and our warehouse tracks atmospheric data during loading and storage. Every incident of temperature spike or condensation during transit gets logged and reviewed for packaging redesign if needed. These steps reduce customer risk and cut waste downstream.
Veterinary practices serve diverse animal populations—ranging from cattle and horses to companion dogs and cats—each with its own response to neuromuscular blockers like Suxamethonium Chloride. Clients often face time-sensitive decisions, such as rapid intubation for airway management or emergency restraint. Our product’s fast action underpins these needs, allowing practitioners to complete interventions quickly and return animals to safety. By focusing on product attributes that matter—rapid dissolution, high lot-to-lot consistency, resistance to clumping or degradation—we align our production process with the urgent requirements seen at animal hospitals and in the field.
Beyond technical performance, practical packaging sizes and forms drive real efficiency for buyers. Veterinary hospitals and compounding pharmacies prefer smaller vials or drum packs that match procedure rates, reducing waste and lowering cost per dose. Feed manufacturers, by contrast, rely on larger drum and bulk options. Learning from the field, we design packing lines to flex between small-batch and high-volume. This adaptation comes from years spent observing actual usage rates and understanding how waste occurs in busy veterinary settings.
As veterinary science evolves, so do requirements for drug inputs. Our R&D team invests in ongoing process improvement—new crystallization methods for tighter impurity profiles, improved drying cycles for lower water content, and alternative forms like micro-granules for the latest compounding trends. Training doesn’t stop at plant operators; our field technical team keeps upskilling alongside advancements in animal pharmacology.
In the past decade, shifts in regulations have required faster response times in documentation and transparency. Digital batch records, on-demand batch certification packs, and real-time traceability from API to end formulation all grew from this push for oversight. Our staff know regulatory change doesn’t wait, so ongoing compliance projects run every quarter.
At the root of every veterinary drug production lay workers and practitioners making daily choices that determine animal wellbeing. Suxamethonium Chloride Veterinary Grade API, shaped by years of experience in industrial scaling, hands-on formulation help, and direct field review, stands not only as a chemical but as an enabler for trustworthy animal care. Everything from drum closure to batch data capture reflects lessons learned from direct customer input.
In animal health, no detail stands unimportant. By carrying years of manufacturing insight—and the willingness to keep learning from every batch, every challenge, every customer story—our team continues to deliver Suxamethonium Chloride Veterinary Grade API with reliability. The bond we share with veterinary professionals runs deeper than a simple transaction; it reflects a shared responsibility to animal lives, livelihoods, and operational success in clinics and farms worldwide.